Page last updated: 2024-09-04

cinacalcet and eplerenone

cinacalcet has been researched along with eplerenone in 3 studies

Compound Research Comparison

Studies
(cinacalcet)
Trials
(cinacalcet)
Recent Studies (post-2010)
(cinacalcet)
Studies
(eplerenone)
Trials
(eplerenone)
Recent Studies (post-2010) (eplerenone)
1,0701556271,036172577

Protein Interaction Comparison

ProteinTaxonomycinacalcet (IC50)eplerenone (IC50)
Mineralocorticoid receptor Homo sapiens (human)0.668
Mineralocorticoid receptorRattus norvegicus (Norway rat)0.0398

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Fottner, C; Weber, MM1
Brown, JM; Heydarpour, M; Mannstadt, M; Parksook, WW; Turchin, A; Vaidya, A1

Reviews

2 review(s) available for cinacalcet and eplerenone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[The latest developments in endocrinology 2004/2005].
    Medizinische Klinik (Munich, Germany : 1983), 2006, Jan-15, Volume: 101, Issue:1

    Topics: Adrenal Gland Neoplasms; Adult; Bone Density Conservation Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Clinical Trials as Topic; Endocrinology; Eplerenone; Female; Humans; Hyperaldosteronism; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hypogonadism; Hypothyroidism; Male; Naphthalenes; Neuroendocrine Tumors; Organometallic Compounds; Osteoporosis, Postmenopausal; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiography, Abdominal; Spironolactone; Teriparatide; Testosterone; Testosterone Congeners; Thiophenes; Time Factors; Tomography, X-Ray Computed

2006

Trials

1 trial(s) available for cinacalcet and eplerenone

ArticleYear
Evaluating the clinical and mechanistic effects of eplerenone and amiloride monotherapy, and combination therapy with cinacalcet, in primary hyperparathyroidism: A placebo-controlled randomized trial.
    Clinical endocrinology, 2023, Volume: 98, Issue:4

    Topics: Aldosterone; Amiloride; Calcium; Cinacalcet; Eplerenone; Female; Humans; Hyperparathyroidism, Primary; Male; Parathyroid Hormone; Renin

2023